David Peereboom Selected Research

David Peereboom Research Topics

Disease

13	Neoplasms (Cancer) 01/2020 - 01/2003
8	Glioma (Gliomas) 02/2022 - 01/2005
6	Brain Neoplasms (Brain Tumor) 02/2022 - 06/2002
5	Glioblastoma (Glioblastoma Multiforme) 10/2020 - 04/2008
3	Neoplasm Metastasis (Metastasis) 05/2015 - 01/2005
2	Breast Neoplasms (Breast Cancer) 10/2013 - 08/2010
2	Lung Neoplasms (Lung Cancer) 10/2013 - 08/2010
2	Neutropenia 08/2010 - 01/2003
2	Oligodendroglioma 04/2009 - 02/2003
2	Prostatic Neoplasms (Prostate Cancer) 03/2005 - 01/2005
1	Acidosis 04/2012
1	Hypoxia (Hypoxemia) 04/2012
1	Hand-Foot Syndrome 08/2010
1	Anemia 08/2010
1	Cystitis 08/2010
1	Pneumonia (Pneumonitis) 08/2010
1	Hemorrhage 08/2008
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 08/2008
1	Fatigue 11/2006
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2006
1	Lymphoma (Lymphomas) 01/2005
1	Disease Progression 01/2005
1	Astrocytoma (Pilocytic Astrocytoma) 02/2003
1	Thrombocytopenia (Thrombopenia) 01/2003

Drug/Important Bio-Agent (IBA)

7	Temozolomide (Temodar)FDA LinkGeneric 02/2022 - 02/2003
3	Docetaxel (Taxotere)FDA Link 08/2010 - 01/2003
2	Bevacizumab (Avastin)FDA Link 10/2020 - 08/2008
2	Pharmaceutical PreparationsIBA 10/2013 - 05/2013
2	CilengitideIBA 10/2013 - 11/2012
2	IntegrinsIBA 10/2013 - 11/2012
2	PlatinumIBA 01/2006 - 01/2005
2	Gemcitabine FDA Link 01/2006 - 01/2003
1	Vorinostat FDA Link 10/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2020
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	tandutinibIBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	fms-Like Tyrosine Kinase 3IBA 01/2017
1	tyrosine receptor (receptor, tyrosine)IBA 01/2017
1	Platelet-Derived Growth FactorIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	iniparibIBA 10/2015
1	ProdrugsIBA 10/2015
1	Biomarkers (Surrogate Marker)IBA 05/2013
1	Biological ProductsIBA 11/2012
1	Excipients (Suspending Agents)IBA 04/2012
1	terameprocolIBA 04/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2010
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2010
1	EnzymesIBA 08/2008
1	cositecanIBA 08/2008
1	Irinotecan (Camptosar)FDA LinkGeneric 08/2008
1	Phenytoin (Dilantin)FDA LinkGeneric 04/2008
1	Celecoxib (Celebrex)FDA Link 04/2008
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2008
1	Interferon-alpha2bIBA 11/2006
1	Estrogen ReceptorsIBA 11/2006
1	Tamoxifen FDA LinkGeneric 11/2006
1	Formaldehyde (Formol)FDA Link 04/2006
1	ParaffinIBA 04/2006
1	Thalidomide (Thalomid)FDA Link 03/2005
1	AndrogensIBA 03/2005
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2005
1	Hormones (Hormone)IBA 01/2005
1	Platinum Compounds (Compounds, Platinum)IBA 01/2005
1	satraplatin (JM 216)IBA 01/2005
1	ElementsIBA 02/2003
1	Sulfhydryl Compounds (Thiols)IBA 06/2002

Therapy/Procedure

8	Therapeutics 02/2022 - 01/2005
4	Drug Therapy (Chemotherapy) 08/2010 - 06/2002
3	Radiotherapy 10/2013 - 04/2009
1	Oral Administration 01/2017
1	Contraindications 08/2008
1	Drug Tapering 11/2006
1	Immunotherapy 01/2005